Skip To Main Content

Artikelen

Sort by

Filters

Resetten
  • Therapeutische gebieden

Cardiac involvement in Fabry disease

Cardiovascular disease is the leading cause of death in Fabry disease patients.1 Undiagnosed and untreated Fabry disease leads to progressive, irreversible, life-threatening heart injury.2,3

Renal involvement in Fabry disease

Think Fabry, think renal involvement that may present early in life and could go undetected.

Family screening

Think Fabry, think screening at-risk family members.1

When to treat

Think Fabry, think early treatment to help slow or prevent life-threatening disease progression.1,2

Pooled analysis: Interventional and observational studies

A post-hoc pooled analysis to evaluate efficacy and safety of insulin glargine 300 U/mL in insulin-naïve people with type 2 diabetes with/ without prior use of glucagon-like peptide-1 receptor agonist therapy.1

What is Toujeo?

How to Use Toujeo®

Atopic dermatitis pathophysiology: type 2 inflammation & cytokines

Beneath the skin of patients with AD—type 2 inflammation and the cytokines involved.

Taming Diabetes: A Daily Challenge for Martin and His Family

Follow 8-year-old Martin and his family as they navigate daily life with type 1 diabetes, from meal adaptations to school activities, showing resilience and optimism.

Living with T1D for 25 Years: Philippe's Inspiring Journey

At the dawn of his fifties, Philippe has tamed the diabetes he has lived with for over 25 years, along with his initial fear of injections. For him, this disease represents "a turning point, not an end." He leads a life "like everyone else," multiplying passions and fully enjoying every moment.

BRIGHT publication

Advancing Treatment for Uncontrolled AD and PN: New Approaches

As we continue to advance in our understanding and treatment capabilities, our response to uncontrolled AD and PN becomes more effective, paving the way for a future where patients can lead healthier, more comfortable lives8.